Overall, PD-L1 expression on tumor cells has been reported in only a subset of DLBCL patients, mainly in those with a non-GC subtype and Epstein-Barr virus (EBV)-associated disease [33,34,35,36,37]. This evidence concerns the gene CD274 and neoplasm.